April 11, 2018, Erie, PA: Outsourced Pharma Boston will feature Mersana Therapeutics as its Spotlight Leadership Company at its conference for professionals of biotech, pharma, and contract development and manufacturing organizations May 14-15, 2018 at the State Room in downtown Boston.
Panelists for this session include the following members of Mersana Therapeutics’ leadership team: Anna Protopapas, President and CEO; Timothy Lowinger, Chief Scientific Officer; and Michael Kaufman, SVP, CMC. The panel will be moderated by Louis Garguilo, Chief Editor & Conference Chair, Outsourced Pharma.
The President & CEO, CSO, and SVP of CMC for Mersana Therapeutics — an exciting Boston-area biotech reliant on strategic partnering — will provide best practices, advice, and real experiences in the art of outsourcing drug development and manufacturing.
“Mersana is pleased to participate in the Outsourced Pharma Boston Conference and feel that our experience in understanding and navigating the complexities of antibody drug conjugate manufacturing with our external research partners will provide attendees with a real-world view into this intricate process,” said Anna Protopapas, President and CEO of Mersana Therapeutics.
Louis Garguilo, Chief Editori and Conference Chair added, “We conclude each Outsourced Pharma conference with a presentation and discussion with an exciting biopharma from the local Outsourced Pharma community. This year we are pleased that Mersana Therapeutics accepted our innovation. Our attendees, other panelists, and our sponsors can all expect to learn some important best practices and actionable information from this great line up of veteran biopharma executives at Mersana. Perhaps as somewhat of a preview, here’s an editorial we did with Mersana’s Michael Kaufman."
With this event in Boston, Outsourced Pharma enters its fifth year of hosting thought leadership conferences and exhibitions that provide discussions of best practices and practical applications of outsourcing skills, with an open format for panel and audience participation. This year’s conference in Boston is titled: Thriving In An Expanded Outsourced Drug Development and Manufacturing Model. All Outsourced Pharma conferences provide opportunities for attendees to learn about specific aspects of biotechnology and pharmaceutical outsourcing, interact with a cross-section of industry members, and generate new business opportunities.
For the full agenda and speaker biographies, visit www.outsourcedpharmaevents.com.
Outsourced Pharma Conference and Exhibition Dates:
Boston | May 14-15, 2018
Philadelphia | July 18-19, 2018
San Diego | August 21-22, 2018
San Francisco | October 29-30, 2018
About Outsourced Pharma Conference and Exhibition
Outsourced Pharma Conference & Exhibition is a vibrant forum for thought-leadership and the application of best practices for professionals engaged in outsourcing drug development and manufacturing. These conferences and exhibitions form a community for networking and discussing topics most relevant to sponsor-provider partnerships and supply-chain management, within an open format that promotes panel and attendee interaction.
OutsourcedPharma.com provides comprehensive analysis of global outsourcing, the biotechnology and pharmaceutical industries, and their intersection with the overall life sciences and healthcare markets. We offer readers a deeper exploration and understanding of the relationships between service providers and their bio and pharma sponsors.
About Life Science Connect
Life Science Connect’s vision is to facilitate connections and foster collaborations in pharmaceutical, biotech, and medical device industries. We facilitate engagement across the drug development life cycle through our web portals, publications, events, and training.